Replies to post #9274 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Rock,

I'm afraid that with Mylan in the game, no matter what their chances are, it will act as a anchor tied around Momenta's leg.

Just like the enoxaparin situation, unless the FDA expressly rejects Mylan which is unlikely, the street will always assume that Mylan will get approved.